Results 131 to 140 of about 1,574,376 (193)

Adenosine A1 receptor (ADORA1) [PDF]

Science-Business eXchange, 2011
openaire   +1 more source

Hypothermia as potential therapeutic approach to attenuating soman-induced seizure, neuropathology, and mortality with an adenosine A₁ receptor agonist and body cooling. [PDF]

Neuropharmacology
Munoz C, Acon-Chen C, Keith ZM, Shih TM.
europepmc   +1 more source

Adenosine A1 receptor: A neuroprotective target in light induced retinal degeneration. [PDF]

PLoS One, 2018
Soliño M, López EM, Rey-Funes M, Loidl CF, Larrayoz IM, Martínez A, Girardi E, López-Costa JJ.   +7 more
europepmc   +1 more source

Downregulation of adenosine and adenosine A1 receptor contributes to neuropathic pain in resiniferatoxin neuropathy. [PDF]

Pain, 2018
Kan HW, Chang CH, Lin CL, Lee YC, Hsieh ST, Hsieh YL.   +5 more
europepmc   +1 more source

Adenosine A1 receptor antagonism prevents DSI in hippocampal CA1 pyramidal cells: PS077. [PDF]

Porto Biomed J, 2017
Freire J, Rombo DM, Sebastião AM.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Adenosine A1 receptor antagonists and the kidney

Current Opinion in Nephrology and Hypertension, 2003
This review will examine the most recent evidence that adenosine receptors in the kidney can alter kidney function. Adenosine A(1)-receptors located in the afferent arteriole and proximal tubule can contribute to fluid retaining disorders by mediating tubuloglomerular feedback, afferent arteriole vasoconstriction or direct sodium absorption.
Paul S, Modlinger, William J, Welch
openaire   +2 more sources

Allosteric modulators for the A1 adenosine receptor

Expert Opinion on Therapeutic Patents, 2004
A review. Allosteric modulators of endogenous adenosine represent an alternative to direct acting adenosine agonists and nucleoside uptake blockers. These compds. can selectively enhance the response to adenosine in only those organs or localized areas of a given organ in which prodn. of adenosine is increased. The present article is an overview of the
BARALDI, Pier Giovanni, MOORMAN ALLAN R., AGHAZADEH TABRIZI, Mojgan, PAVANI, Maria Giovanna, ROMAGNOLI, Romeo   +4 more
openaire   +2 more sources

Adenosine A1 receptors and erythropoietin production

American Journal of Physiology-Cell Physiology, 1993
N6-cyclopentyladenosine (CPA), a selective adenosine A1 receptor agonist, in a concentration range of 10(-9) to 10(-7) M, produced a significant decrease in erythropoietin (EPO) levels in a human hepatocellular carcinoma (Hep G2) cell culture (medium levels of EPO, 91.81 +/- 1.61 and 94.36 +/- 0.97% of control, respectively) after 24 h incubation in a
T, Ohigashi, J, Brookins, J W, Fisher
openaire   +2 more sources

Binding of an adenosine A1 receptor agonist and adenosine A1 receptor antagonist to sheep pineal membranes

European Journal of Pharmacology, 1997
The pineal organ of vertebrates produces melatonin and adenosine. In lower vertebrates, adenosine modulates melatonin production. We report herein that 2-chloro-cyclopentyl-[3H]-adenosine ([3H]CCPA: adenosine A1 receptor agonist) and [3H]-cyclopentyl-1,3-dipropylxanthine ([3H]DPCPX: adenosine A1 receptor antagonist), bind specifically to sheep pineal ...
Falcon, J., Privat, K., Ravault, J.P.
openaire   +3 more sources

Allosteric modulation of A1-adenosine receptor: a review

Drug Discovery Today: Technologies, 2013
Allosteric modulators of adenosine receptors represent an alternative to direct-acting adenosine agonists and nucleoside uptake blockers, preferably those can selectively modulate the response to adenosine in only those organs or localized areas of a given organ in which production of adenosine is increased.
M. Kimatrai Salvador, BARALDI, Pier Giovanni, ROMAGNOLI, Romeo   +2 more
openaire   +2 more sources